TuHURA Biosciences Files 8-K: Shareholder Vote, Reg FD, Exhibits
Ticker: HURA · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1498382
Sentiment: neutral
Topics: corporate-action, regulatory-filing, shareholder-vote
TL;DR
TuHURA Biosciences filed an 8-K on 6/23, covering shareholder votes, Reg FD, and financials. Major updates incoming.
AI Summary
TuHURA Biosciences, Inc. filed an 8-K on June 24, 2025, reporting events as of June 23, 2025. The filing indicates a submission of matters to a vote of security holders, a Regulation FD disclosure, and financial statements and exhibits. The company, formerly known as Kintara Therapeutics, Inc., is incorporated in Nevada and headquartered in Tampa, Florida.
Why It Matters
This 8-K filing signals important corporate actions, including potential shareholder votes and regulatory disclosures, which could impact investor decisions and the company's operational direction.
Risk Assessment
Risk Level: medium — 8-K filings can signal significant corporate events, but the specific details of the 'matters to a vote' and 'Regulation FD disclosure' are not yet elaborated, requiring further investigation.
Key Players & Entities
- TuHURA Biosciences, Inc. (company) — Registrant
- Kintara Therapeutics, Inc. (company) — Former company name
- June 23, 2025 (date) — Earliest event date
- June 24, 2025 (date) — Filing date
- Nevada (jurisdiction) — State of incorporation
- Tampa, Florida (location) — Principal executive address
FAQ
What specific matters are being submitted to a vote of TuHURA Biosciences' security holders?
The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in this summary.
What is the nature of the Regulation FD Disclosure mentioned in the filing?
The filing lists 'Regulation FD Disclosure' as an item, but the content of this disclosure is not detailed in the provided text.
When was TuHURA Biosciences, Inc. formerly known as Kintara Therapeutics, Inc.?
The filing states the former company name was Kintara Therapeutics, Inc., with a date of name change not specified in this excerpt, but the current filing is for TuHURA Biosciences, Inc.
Where is TuHURA Biosciences, Inc. headquartered?
TuHURA Biosciences, Inc.'s principal executive address is listed as 10500 University Center Dr., Suite 110, Tampa, Florida 33612.
What is the SIC code for TuHURA Biosciences, Inc.?
The Standard Industrial Classification (SIC) code for TuHURA Biosciences, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding TuHURA Biosciences, Inc./NV (HURA).